 | Up a level |
Journal Article
Ataseven, B., Rhiem, K., Staniczok, C., Heitz, F., Pauly, N., Moubarak, M., Concin, N., Traut, A., Schmutzler, R. and Harter, P. (2022). Prevalence and oncological outcome of patients with primary epithelial ovarian cancer (EOC) carrying gene mutations or variants of unknown signifikance (VUS) detected by germline gene panel testing. Geburtshilfe Frauenheilkd., 82 (10). S. E44 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Ataseven, B., Tripon, D., Schwameis, R., Harter, P., Rhiem, K., Schneider, S., Heikaus, S., Baert, T., Alesina, P., Heitz, F., Traut, A., Groeben, H. T., Schmutzler, R. and du Bois, A. (2021). Impact of BRCA1/2 Germline Status on intraperitoneal Tumor Distribution, Operability, and Incidence of postoperative Complications in Patients with epithelial Ovarian Cancer. Geburtshilfe Frauenheilkd., 81 (4). S. E2 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Heitz, F., Ataseven, B., Moubarak, M., Staniczok, C., Schmutzler, R., Schameis, R., Heikaus, S., Concin, N., Riehm, K., Denkert, C. and Harter, P. (2022). HRD Testing and BRCA1/2 Germline Testing in Routine Clinical Practice in Patients with primary Ovarian Cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E86 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Holly, J., Harter, P., Ataseven, B., Moubarak, M., Schwameis, R., Heikaus, S., Concin, N., Rhiem, K., Denkert, C. and Heitz, F. (2022). HRD Testing and BRCA1/2 Germline Testing in routine clinical Practice in Female Patients with primary Ovarian Cancer. Geburtshilfe Frauenheilkd., 82 (4). S. E5 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Imterat, M., du Bois, A., Harter, P., Rhiem, K., Heitz, F., Concin, N., Traut, A., Schmutzler, R. and Ataseven, B. (2022). Incidence and prognostic impact of pathogenic germline mutations in gene panel testing of primary advanced epithelial ovarian cancer patients. Geburtshilfe Frauenheilkd., 82 (10). S. E97 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Pauly, N., Harter, P., Heitz, F., Schoemig-Markiefka, B., Moubarak, M., Traut, A., Kaiser, S. and Ataseven, B. (2022). MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer.Defining a new subgroup? Geburtshilfe Frauenheilkd., 82 (10). S. E138 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Rhiem, K., Richters, L., Hahnen, E., Lampe, B., Rezai, M., Goehring, U. -J., Schumacher, C., Kuemmel, S., Ataseven, B. and Schmutzler, R. (2016). Benchmarking of the DKG check list for inclusion criteria of BRCA testing. Oncol. Res. Treat., 39. S. 59 - 60. BASEL: KARGER. ISSN 2296-5262
Staniczok, C., Ataseven, B., Heitz, F., Harter, P., Rhiem, K., Pauly, N., Traut, A. and Moubarak, M. (2022). Prevalence and clinical characterization of concurrent multiple deleterious germline mutations in German patients with epithelial ovarian cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E165 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804